Dr Amina Faham, Senior Global Manager, R&D Pharma, The DOW Chemical Company. Amina earned a Ph.D. degree in Pharmaceutical Sciences from school of Pharmacy, University de la Mediterranée France. Amina has over 15years of pharma industry experience in oral solid dosage forms with emphasis on modified drug release technologies, process development and optimization, and project management with companies including Ethypharm, Pfizer Pharmaceuticals and Colorcon, all based in North America region. Amina has a strong background and experience of fundamental areas which apply to drug delivery, risk management, control strategy and pharmaceutical market analysis. She has strong knowledge on regulatory affairs support of submissions and on-going regulatory compliance for product development process. She joined DOW Europe in Switzerland in 2011, as a pharmaceutical application specialist to drive and support the pharma business growth in Europe Middle East and Africa, and then moved into a global leadership role in Pharma R&D organization. Since May 2018, Amina’s new role is to head the Global Pharma Application Development & Innovation within Nutrition & Health Business. One of Amina’s main responsibilities is to use her pharmaceutical technical and scientific expertise to closely connect to the innovation needs of the pharmaceutical industry. Amina is a member ofthe DOW Swiss Commercial Excellence team and a member of the DOW Women Innovation Network Europe Middle East Africa and India Steering Committee. Amina is also a lecturer at Zurich Federal Institute of Technology (ETH) and an executive board member of the International Pharmaceutical Excipients Council (IPEC) in Europe.